These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 38095084

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.
    Freitas de Freitas T, Roth CD, Abbadi BL, Hopf FSM, Perelló MA, de Matos Czeczot A, de Souza EV, Borsoi AF, Machado P, Bizarro CV, Basso LA, Timmers LFSM.
    J Comput Aided Mol Des; 2023 Mar; 37(3):117-128. PubMed ID: 36547753
    [Abstract] [Full Text] [Related]

  • 3. Identification of novel antimicrobial compounds targeting Mycobacterium tuberculosis shikimate kinase using in silico hierarchical structure-based drug screening.
    Kawamoto S, Hori C, Taniguchi H, Okubo S, Aoki S.
    Tuberculosis (Edinb); 2023 Jul; 141():102362. PubMed ID: 37311288
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of irreversible inhibition of Mycobacterium tuberculosis shikimate kinase by ilimaquinone.
    Simithy J, Fuanta NR, Hobrath JV, Kochanowska-Karamyan A, Hamann MT, Goodwin DC, Calderón AI.
    Biochim Biophys Acta Proteins Proteom; 2018 Jul; 1866(5-6):731-739. PubMed ID: 29654976
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids.
    Simithy J, Fuanta NR, Alturki M, Hobrath JV, Wahba AE, Pina I, Rath J, Hamann MT, DeRuiter J, Goodwin DC, Calderón AI.
    Biochemistry; 2018 Aug 14; 57(32):4923-4933. PubMed ID: 30063132
    [Abstract] [Full Text] [Related]

  • 11. Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials.
    Gordon S, Simithy J, Goodwin DC, Calderón AI.
    Perspect Medicin Chem; 2015 Aug 14; 7():9-20. PubMed ID: 25861218
    [Abstract] [Full Text] [Related]

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 14; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
    Pereira JH, de Oliveira JS, Canduri F, Dias MV, Palma MS, Basso LA, Santos DS, de Azevedo WF.
    Acta Crystallogr D Biol Crystallogr; 2004 Dec 14; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
    [Abstract] [Full Text] [Related]

  • 16. The mode of action of recombinant Mycobacterium tuberculosis shikimate kinase: kinetics and thermodynamics analyses.
    Rosado LA, Vasconcelos IB, Palma MS, Frappier V, Najmanovich RJ, Santos DS, Basso LA.
    PLoS One; 2013 Dec 14; 8(5):e61918. PubMed ID: 23671579
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 14; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 19. In silico discovery of potential drug molecules to improve the treatment of isoniazid-resistant Mycobacterium tuberculosis.
    Jagadeb M, Rath SN, Sonawane A.
    J Biomol Struct Dyn; 2019 Aug 14; 37(13):3388-3398. PubMed ID: 30132739
    [Abstract] [Full Text] [Related]

  • 20. Exploring biogenic chalcones as DprE1 inhibitors for antitubercular activity via in silico approach.
    Rathod S, Chavan P, Mahuli D, Rochlani S, Shinde S, Pawar S, Choudhari P, Dhavale R, Mudalkar P, Tamboli F.
    J Mol Model; 2023 Mar 27; 29(4):113. PubMed ID: 36971900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.